Cargando…
Donor-Specific Cell-Free DNA qPCR Quantification as a Noninvasive Accurate Biomarker for Early Rejection Detection in Liver Transplantation
(1) Background: Graft-cell-free DNA (cfDNA) in the circulation of liver transplant recipients has been proposed as a noninvasive biomarker of organ rejection. The aim of this study was to detect donor-specific cfDNA (ds-cfDNA) in the recipient’s serum after either liver damage or rejection using a q...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821236/ https://www.ncbi.nlm.nih.gov/pubmed/36614837 http://dx.doi.org/10.3390/jcm12010036 |
_version_ | 1784865649293524992 |
---|---|
author | García-Fernández, Noelia Macher, Hada C. Suárez-Artacho, Gonzalo Gómez-Bravo, Miguel Ángel Molinero, Patrocinio Guerrero, Juan Miguel Porras-López, Manuel Rubio, Amalia |
author_facet | García-Fernández, Noelia Macher, Hada C. Suárez-Artacho, Gonzalo Gómez-Bravo, Miguel Ángel Molinero, Patrocinio Guerrero, Juan Miguel Porras-López, Manuel Rubio, Amalia |
author_sort | García-Fernández, Noelia |
collection | PubMed |
description | (1) Background: Graft-cell-free DNA (cfDNA) in the circulation of liver transplant recipients has been proposed as a noninvasive biomarker of organ rejection. The aim of this study was to detect donor-specific cfDNA (ds-cfDNA) in the recipient’s serum after either liver damage or rejection using a qPCR-based method. (2) Methods: We proposed a qPCR method based on the amplification of 10 specific insertion–deletion (InDel) polymorphisms to detect donor-specific circulating DNA diluted in the recipient cfDNA. ds-cfDNA from 67 patients was evaluated during the first month post-transplantation. (3) Results: Graft rejection in the first month post-transplantation was reported in 13 patients. Patients without liver complications showed a transitory increase in ds-cfDNA levels at transplantation. Patients with rejection showed significant differences in ds-cfDNA increase over basal levels at both the rejection time point and several days before rejection. Receiver operator characteristic (ROC) analysis showed that ds-cfDNA levels discriminated rejection, with an AUC of 0.96. Maximizing both sensitivity and specificity, a threshold cutoff of 8.6% provided an estimated positive and negative predictive value of 99% and 60%, respectively. (4) Conclusions: These results suggest that ds-cfDNA may be a useful marker of graft integrity in liver transplant patients to screen for rejection and liver damage. |
format | Online Article Text |
id | pubmed-9821236 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98212362023-01-07 Donor-Specific Cell-Free DNA qPCR Quantification as a Noninvasive Accurate Biomarker for Early Rejection Detection in Liver Transplantation García-Fernández, Noelia Macher, Hada C. Suárez-Artacho, Gonzalo Gómez-Bravo, Miguel Ángel Molinero, Patrocinio Guerrero, Juan Miguel Porras-López, Manuel Rubio, Amalia J Clin Med Article (1) Background: Graft-cell-free DNA (cfDNA) in the circulation of liver transplant recipients has been proposed as a noninvasive biomarker of organ rejection. The aim of this study was to detect donor-specific cfDNA (ds-cfDNA) in the recipient’s serum after either liver damage or rejection using a qPCR-based method. (2) Methods: We proposed a qPCR method based on the amplification of 10 specific insertion–deletion (InDel) polymorphisms to detect donor-specific circulating DNA diluted in the recipient cfDNA. ds-cfDNA from 67 patients was evaluated during the first month post-transplantation. (3) Results: Graft rejection in the first month post-transplantation was reported in 13 patients. Patients without liver complications showed a transitory increase in ds-cfDNA levels at transplantation. Patients with rejection showed significant differences in ds-cfDNA increase over basal levels at both the rejection time point and several days before rejection. Receiver operator characteristic (ROC) analysis showed that ds-cfDNA levels discriminated rejection, with an AUC of 0.96. Maximizing both sensitivity and specificity, a threshold cutoff of 8.6% provided an estimated positive and negative predictive value of 99% and 60%, respectively. (4) Conclusions: These results suggest that ds-cfDNA may be a useful marker of graft integrity in liver transplant patients to screen for rejection and liver damage. MDPI 2022-12-21 /pmc/articles/PMC9821236/ /pubmed/36614837 http://dx.doi.org/10.3390/jcm12010036 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article García-Fernández, Noelia Macher, Hada C. Suárez-Artacho, Gonzalo Gómez-Bravo, Miguel Ángel Molinero, Patrocinio Guerrero, Juan Miguel Porras-López, Manuel Rubio, Amalia Donor-Specific Cell-Free DNA qPCR Quantification as a Noninvasive Accurate Biomarker for Early Rejection Detection in Liver Transplantation |
title | Donor-Specific Cell-Free DNA qPCR Quantification as a Noninvasive Accurate Biomarker for Early Rejection Detection in Liver Transplantation |
title_full | Donor-Specific Cell-Free DNA qPCR Quantification as a Noninvasive Accurate Biomarker for Early Rejection Detection in Liver Transplantation |
title_fullStr | Donor-Specific Cell-Free DNA qPCR Quantification as a Noninvasive Accurate Biomarker for Early Rejection Detection in Liver Transplantation |
title_full_unstemmed | Donor-Specific Cell-Free DNA qPCR Quantification as a Noninvasive Accurate Biomarker for Early Rejection Detection in Liver Transplantation |
title_short | Donor-Specific Cell-Free DNA qPCR Quantification as a Noninvasive Accurate Biomarker for Early Rejection Detection in Liver Transplantation |
title_sort | donor-specific cell-free dna qpcr quantification as a noninvasive accurate biomarker for early rejection detection in liver transplantation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821236/ https://www.ncbi.nlm.nih.gov/pubmed/36614837 http://dx.doi.org/10.3390/jcm12010036 |
work_keys_str_mv | AT garciafernandeznoelia donorspecificcellfreednaqpcrquantificationasanoninvasiveaccuratebiomarkerforearlyrejectiondetectioninlivertransplantation AT macherhadac donorspecificcellfreednaqpcrquantificationasanoninvasiveaccuratebiomarkerforearlyrejectiondetectioninlivertransplantation AT suarezartachogonzalo donorspecificcellfreednaqpcrquantificationasanoninvasiveaccuratebiomarkerforearlyrejectiondetectioninlivertransplantation AT gomezbravomiguelangel donorspecificcellfreednaqpcrquantificationasanoninvasiveaccuratebiomarkerforearlyrejectiondetectioninlivertransplantation AT molineropatrocinio donorspecificcellfreednaqpcrquantificationasanoninvasiveaccuratebiomarkerforearlyrejectiondetectioninlivertransplantation AT guerrerojuanmiguel donorspecificcellfreednaqpcrquantificationasanoninvasiveaccuratebiomarkerforearlyrejectiondetectioninlivertransplantation AT porraslopezmanuel donorspecificcellfreednaqpcrquantificationasanoninvasiveaccuratebiomarkerforearlyrejectiondetectioninlivertransplantation AT rubioamalia donorspecificcellfreednaqpcrquantificationasanoninvasiveaccuratebiomarkerforearlyrejectiondetectioninlivertransplantation |